Amitriptylinoxide
Clinical data | |
---|---|
Trade names | Amioxid, Ambivalon, Equilibrin |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Amitriptylinoxide (brand names Amioxid, Ambivalon, Equilibrin), or amitriptyline N-oxide, is a tricyclic antidepressant (TCA) which was introduced in Europe in the 1970s for the treatment of depression.[1]
Amitriptylinoxide is both an
In
α1-adrenergic receptor, and the weakest affinity of any of the TCAs analyzed for the muscarinic acetylcholine receptors.[8][9][10]
Amitriptylinoxide has been said to be a prodrug of amitriptyline.[11]
See also
References
- ISBN 3-88763-075-0.
- ^ S2CID 12666498.
- ^ S2CID 956047.
- ^ PMID 4945956.
- ^ ISBN 978-0-444-53266-4.
- PMID 261811.
- PMID 4947298.
- S2CID 31927039.
- S2CID 25823571.
- PMID 7395525.
- ISBN 978-3-527-64632-6.